Company Filing History:
Years Active: 1998-2000
Title: **Peter Ham: A Pioneer in Receptor Antagonist Research**
Introduction
Peter Ham, an innovative inventor based in Harlow, GB, has made significant contributions to the field of pharmacology with his extensive research and patent filings. With a remarkable portfolio of four patents, he stands out in the industry for his work in the development of receptor antagonists.
Latest Patents
Among Peter Ham's notable contributions are his latest patents, which include:
1. Tetracyclic spiro compounds as 5HT1B receptor antagonists.
2. Pyridil carboxamides as 5HT2B/2C receptor antagonists.
These inventions reflect his dedication to advancing medical science and improving therapeutic options.
Career Highlights
Peter Ham is currently associated with the SmithKline Beecham Corporation, where he applies his expertise in drug development and innovation. His work has had a meaningful impact on the pharmaceutical field, particularly in understanding and targeting serotonin receptors.
Collaborations
Throughout his career, Peter has collaborated with notable professionals, including Ian Thomson Forbes and Graham Elgin Jones. These partnerships have undoubtedly enriched his research and broadened his contributions to the scientific community.
Conclusion
Peter Ham's innovative spirit and commitment to research exemplify the qualities of a distinguished inventor. With his significant number of patents and collaborative efforts, he continues to influence the landscape of pharmacological research, paving the way for future advancements in medicine.